Log in

Antioxidant Properties, Neuroprotective Effects and in Vitro Safety Evaluation of New Pyrrole Derivatives

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

The paper is focused on safety evaluation, antioxidant activity and neuroprotective properties determination of newly synthesized substituted N-pyrrolyl hydrazide hydrazones on two neuronal in vitro models: human neuronal cells SH-SY5Y and isolated rat brain synaptosomes. Preliminary toxicological data indicated low or no in vitro toxicity for all evaluated substances, where compounds 9a and 9d were extracted as safest and most promising structures with lowest neurotoxicity. Performed neuroprotective evaluations showed statistically significant neuroprotective effects on two applied models of induced oxidative stress, with most pronounced effect observed for 9a being comparable with that of melatonin. Statistically significant inhibitory activity on human recombinant MAO-B enzyme, close to that of selegiline and better than that melatonin, was only found for compound 9a.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Thailand)

Instant access to the full article PDF.

Fig. 1.
Scheme 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.
Fig. 6.
Fig. 7.
Fig. 8.
Fig. 9.

Similar content being viewed by others

References

  1. A. Singh, R. Kukreti, L. Saso, and S. Kukreti, Molecules, 24(8), 1583 (2019).

    Article  CAS  PubMed Central  Google Scholar 

  2. K. S. Cho, M. Shin, S. Kim, and S. B. Lee, Oxid. Med. Cell. Longev., 2018 (2018).

  3. H. Fischer and H. Orth, Die Chemie des Pyrrols, Akademische Verlagsgesellschaftmbh., Leipzig (1934).

  4. R. A. Jones, Pyrroles: The Synthesis and the Physical and Chemical Aspects of the Pyrrole ring, Wiley-Interscience (1990).

    Google Scholar 

  5. A. Thurkauf, J. Yuan, N. Chen, et al., J. Med. Chem., 38(25), 4950 – 4952 (1995).

    Article  CAS  PubMed  Google Scholar 

  6. W. W. Wilkerson, R. A. Copeland, M. Covington, and J. M. Trzaskos, J. Med. Chem., 38(20), 3895 – 3901 (1995).

    Article  CAS  PubMed  Google Scholar 

  7. H. I. Zlatanova, S. P. Vladimirova, I. D. Kostadinov, et al., Int. J. Pharm. Clin. Res., 8(11), 1483 – 1488 (2016).

    Google Scholar 

  8. H. Zlatanova, S. Vladimirova, I. Kostadinov, et al., Int. J. Pain Manag., 1(1), 1 – 12 (2017).

    Article  Google Scholar 

  9. H. Zlatanova, S. Vladimirova, I. Kandilarov, et al., Eur. Neuropsychopharmacol., 27, S670 – S671 (2017).

    Article  Google Scholar 

  10. H. Zlatanova, S. Vladimirova, I. Kostadinov, and A. T. Bijev, Folia Med., 60(2), 270 – 274 (2018).

    Article  CAS  Google Scholar 

  11. H. Zlatanova, S. Vladimirova, I. Kandilarov, et al., Eur. Neuropsychopharmacol., 29, S468 – S469 (2019).

    Article  Google Scholar 

  12. A. Kajal, S. Bala, N. Sharma, et al., Int. J. Med. Chem., 2014 (2014).

  13. K. N. de Oliveira, P. Costa, J. R. Santin, et al., Bioorg. Med. Chem., 19(14), 4295 – 4306 (2011).

    Article  PubMed  Google Scholar 

  14. C. M. Leal, S. L. Pereira, A. E. Kümmerle, et al., Eur. J. Med. Chem., 55, 49 – 57 (2012).

    Article  CAS  PubMed  Google Scholar 

  15. L. Yurttaþ, Y. Özkay, Z. A. Kaplancýklý, et al., J. Enzyme Inhib. Med. Chem., 28(4), 830 – 835 (2013).

    Article  Google Scholar 

  16. O. O. Ajani, C. A. Obafemi, O. C. Nwinyi, and D. A. Akinpelu, Bioorg. Med. Chem., 18(1), 214 – 221 (2010).

    Article  CAS  PubMed  Google Scholar 

  17. J. V. Ragavendran, D. Sriram, S. K. Patel, et al., Eur. J. Med. Chem., 42(2), 146 – 151 (2007).

    Article  CAS  PubMed  Google Scholar 

  18. J. R. Dimmock, S. C. Vashishtha, and J. P. Stables, Eur. J. Med. Chem., 35(2), 241 – 248 (2000).

    Article  CAS  PubMed  Google Scholar 

  19. S. I. Alqasoumi, M. M. Ghorab, Z. H. Ismail, et al., Arzneimittelforschung, 59(12), 666 – 671 (2009).

    CAS  PubMed  Google Scholar 

  20. Y. **a, C. D. Fan, B. X. Zhao, et al., Eur. J. Med. Chem., 43(11), 2347 – 2353 (2008).

    Article  CAS  PubMed  Google Scholar 

  21. R. M. Mohareb, D. H. Fleita, and O. K. Sakka, Molecules, 16(1), 16 – 27 (2011).

    Article  CAS  Google Scholar 

  22. A. A. El-Tombary and S. A. M. El-Hawash, Med. Chem., 10(5), 521 – 532 (2014).

    Article  CAS  PubMed  Google Scholar 

  23. P. D. MacLean, E. E. Chapman, S. L. Dobrowolski, et al., J. Org. Chem., 73(17), 6623 – 6635 (2008).

    Article  CAS  PubMed  Google Scholar 

  24. R. Zamora, M. Alaiz, and F. J. Hidalgo, Biochemistry, 36(50), 15765 – 15771 (1997).

    Article  CAS  PubMed  Google Scholar 

  25. R. Zamora, M. Alaiz, and F. J. Hidalgo, Chem. Res. Toxicol., 12(7), 654 – 660 (1999).

    Article  CAS  PubMed  Google Scholar 

  26. J. D. Bhosale, A. R. Shirolkar, U. D. Pete, et al., J. Pharm. Res., 7(7), 582 – 587 (2013).

    CAS  Google Scholar 

  27. A. Khalilpour and S. Asghari, Med. Chem. Res., 27(1), 15 – 22 (2018).

    Article  CAS  Google Scholar 

  28. G. La Regina, R. Silvestri, M. Artico, et al., J. Med. Chem., 50(5), 922 – 931 (2007).

    Article  PubMed  Google Scholar 

  29. S. Suzen, S. S. Cihaner, and T. Coban, Chem. Biol. Drug Des., 79(1), 76 – 83 (2012).

    Article  CAS  PubMed  Google Scholar 

  30. Z. Peng, G. Wang, Q. H. Zeng, et al., Food Chem., 128265 (2020).

  31. M. O. Puskullu, H. Shirinzadeh, M. Nenni, et al., J. Enzyme Inhib. Med. Chem., 31(1), 121 – 125 (2016).

    Article  CAS  PubMed  Google Scholar 

  32. S. Shetty and B. Kalluraya, Der Pharma Chem., 7(12), 26 – 32 (2015).

    CAS  Google Scholar 

  33. U. A. Çevik, D. Osmaniye, B. N. Saðlik, et al., Med. Chem. Res., 1 – 12 (2020).

  34. D. G. Tzankova, S. P. Vladimirova, L. P. Peikova, and M. B. Georgieva, Bulg. Chem. Commun., 51(A), 179 – 185 (2019).

    Google Scholar 

  35. B. C. Evans, C. E. Nelson, S. Y. Shann, et al., J. Vis. Exp., 73, e50166 (2013).

    Google Scholar 

  36. T. Mosmann, J. Immunol. Methods, 65(1 – 2), 55 – 63 (1983).

  37. O. M. Bautista-Aguilera, G. Esteban, I. Bolea, et al., Eur. J. Med. Chem., 75, 82 – 95 (2014).

    Article  CAS  PubMed  Google Scholar 

  38. P. Taupin, S. Zini, F. Cesselin, et al., J. Neurochem., 62(4), 1586 – 1595 (1994).

    Article  CAS  PubMed  Google Scholar 

  39. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, J. Biol. Chem., 193, 265 – 275 (1951).

    Article  CAS  PubMed  Google Scholar 

  40. J. F. Robyt, R. J. Ackerman, and C. G. Chittenden, Arch. Biochem. Biophys., 147(1), 262 – 269 (1971).

    Article  CAS  PubMed  Google Scholar 

  41. A. H. Stokes, T. G. Hastings, and K. E. Vrana, J. Neurosci. Res., 55(6), 659 – 665 (1999).

    Article  CAS  PubMed  Google Scholar 

  42. European Union Reference Laboratory for alternatives to animal testing - EURL ECVAM. https://ec.europa.eu/jrc/en/eurl/ecvam; access date: 21 December 2020.

  43. R. A. Coleman, W. P. Bowen, I. A. Baines, et al., Drug Discov. Today., 6(21), 1116 – 1126 (2001).

    Article  CAS  PubMed  Google Scholar 

  44. D. M. Cross and M. K. Bayliss, Drug metab. rev., 32(2), 219 – 240 (2000).

    Article  CAS  PubMed  Google Scholar 

  45. R. J. Reiter, Adv. Pharmacol., 38, 103 – 117 (1996).

    Article  Google Scholar 

  46. J. M. Mack, T. de Menezes Moura, F. Bobinski, et al., Neurotoxicology, 80, 144 – 154 (2020).

    Article  CAS  PubMed  Google Scholar 

  47. R. Hardeland, B. Poeggeler, R. Niebergall, and V. Zelosko, J. Pineal Res., 34(1), 17 – 25 (2003).

    Article  CAS  PubMed  Google Scholar 

  48. R. J. Reiter, D. X. Tan, R. M. Sainz, et al., Afr. J. Pharm. Pharmacol., 54(10), 1299 – 1321 (2002).

    Article  CAS  Google Scholar 

  49. A. H. Stokes, W. M. Freeman, S. G. Mitchell, et al., Neurotoxicology, 23(6), 675 – 684 (2002).

    Article  CAS  PubMed  Google Scholar 

  50. C. Rodrigues, J. C. Mayo, R. M. Sainz, et al., J. Pineal Res., 36(1), 1 – 9 (2004).

    Article  Google Scholar 

  51. C. Pieri, M. Marra, F. Moroni, et al., Life Sci., 55(15), 271 – 276 (1994).

    Article  Google Scholar 

  52. D. X. Tan, L. C. Manchester, R. J. Reiter, et al., Biol. Signals Recept., 9, 137 – 159 (2000).

    Article  CAS  PubMed  Google Scholar 

  53. C. D. Albendea, E. M. Gomez-Trullen, L. Fuentes-Broto, et al., J. Trace Elem. Med. Biol., 21, 261 – 268 (2007).

    Article  CAS  PubMed  Google Scholar 

Download references

CONFLICT OF INTEREST

The authors declare that they have no conflicts of interest.

Funding

This work was supported by the Bulgarian Ministry of Education and Science under the National Program for Research “Young Scientists and Postdoctoral Students.”

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Diana Tzankova.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tzankova, D., Aluani, D., Kondeva-Burdina, M. et al. Antioxidant Properties, Neuroprotective Effects and in Vitro Safety Evaluation of New Pyrrole Derivatives. Pharm Chem J 55, 1310–1319 (2022). https://doi.org/10.1007/s11094-022-02577-3

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-022-02577-3

Keywords

Navigation